• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.05% Nasdaq Down 1.26%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    8.40 Down 0.42(4.76%) 12:21PM EDT - Nasdaq Real Time Price
    Prev Close:8.82
    Open:8.65
    Bid:8.36 x 500
    Ask:8.37 x 800
    1y Target Est:9.17
    Beta:1.93117
    Earnings Date:May 5 - May 9 (Est.)
    Day's Range:8.12 - 8.76
    52wk Range:5.57 - 11.05
    Volume:1,063,470
    Avg Vol (3m):1,598,600
    Market Cap:1.15B
    P/E (ttm):N/A
    EPS (ttm):-0.04
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACHN

    Comparison

    Symbol% ChgMkt Cap
    ACHNDown 4.76%1.15B
    GSKDown 0.37%104.37B
    JNJDown 0.15%310.53B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.62
    Quarterly EPS Est (Mar-16) :-0.14
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.81

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback